Results

Total Results: 690 records

Showing results for "therapeutic".

161. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/837215/psn-pdf
     July 08, 2022 - activator) for intravenous thrombolysis in acute ischemic stroke and, more recently, endovascular therapy … to be at their neurological baseline.1 This extended time window primarily applies to endovascular therapy … The therapeutic time window for acute ischemic stroke is relatively narrow, and any delays in diagnosis … window for endovascular treatment. … mechanical thrombectomy, such as observing for a clinical response after intravenous thrombolytic therapy

162. Getting the Medicines Right. | PSNet
     psnet.ahrq.gov/issue/getting-medicines-right
     January 26, 2022 - impact of pharmacological/pharmaceutical care on medication safety and patient-reported outcomes during treatment … February 17, 2021 Use of therapeutic outcomes monitoring method for performing of pharmaceutical

163. Diseases of medical progress. | PSNet
     psnet.ahrq.gov/issue/diseases-medical-progress
     June 27, 2018 - that the history of medicine provides numerous examples of how emerging illnesses develop from sound therapeutic … The author discusses more than 40 distinct entities that resulted from new and existing medication therapies … fascinating historical perspective, one that not only raises concern over all currently available novel therapies

164. Spotlight Case July 2008 (ppt file)
     psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.182_slideshow.ppt
     September 01, 2008 - factors for “atypical” causes, such as the patient being an immigrant, closer look is warranted Specific therapies … The Presented Case Glucocorticoids not helpful in Strongyloides stercoralis Proper therapeutic regimen … of RA Randomized trial compared treatment strategies: Initial combination therapy with methotrexate … , sulfasalazine, and rapidly tapered high-dose prednisone therapy Initial combination therapy with methotrexate … disease” Drug can be stopped if patient does not improve, or if cause for which there are specific therapies

165. Patient safety outcomes under flexible and standard resident duty-hour rules. | PSNet
     psnet.ahrq.gov/issue/patient-safety-outcomes-under-flexible-and-standard-resident-duty-hour-rules
     March 13, 2019 - An accompanying editorial calls for eliciting patient perspectives about trainee duty hours and the therapeutic

166. US poison control center calls for infants 6 months of age and younger. | PSNet
     psnet.ahrq.gov/issue/us-poison-control-center-calls-infants-6-months-age-and-younger
     November 16, 2022 - Therapeutic errors, such as dosing mistakes , accounted for another 37% of exposures.

167. Citrate Mix-Up | PSNet
     psnet.ahrq.gov/web-mm/citrate-mix
     February 01, 2010 - and chronic renal failure was transferred from a skilled nursing facility (SNF) to the hospital for treatment … This error led to increased patient monitoring and drug treatment to normalize the serum potassium and … The formulary review process of the Pharmacy and Therapeutics Committee can be a forum to discuss limiting … The hospital's Pharmacy and Therapeutics Committee can develop prescribing guidelines for using these … citrate agents that inform staff of their differences and suggest therapeutic alternatives.

168. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/50701/psn-pdf
     November 26, 2019 - The therapeutic window for many of our interventions is much narrower in these patients. … young people and instead really pay attention to the potential short-term consequences of misjudging treatment … Medication is such a key part of our therapeutic efforts. … However, there is a narrower therapeutic window in our frail older patients.

169. Epidemiology of medical error. | PSNet
     psnet.ahrq.gov/issue/epidemiology-medical-error
     March 29, 2012 - Following this background, they discuss types of error, including complications from drug treatment, … therapeutic mishaps, and diagnostic failures.

170. Reducing error in anticoagulant dosing via multidisciplinary team rounding at point of care. | PSNet
     psnet.ahrq.gov/issue/reducing-error-anticoagulant-dosing-multidisciplinary-team-rounding-point-care
     November 16, 2016 - Anticoagulants are considered high-risk medications due to their narrow therapeutic window and association … January 27, 2019 Impact of pharmacist-provided medication therapy management on healthcare

171. Improving transitions of care for patients on warfarin: the Safe Transitions Anticoagulation Report. | PSNet
     psnet.ahrq.gov/issue/improving-transitions-care-patients-warfarin-safe-transitions-anticoagulation-report
     April 22, 2011 - received by outpatient physicians, but it did not appreciably affect processes of care measures or therapeutic … September 29, 2021 To expand the evidence base about harms from tests and treatments.

172. Opioid abuse in chronic pain—misconceptions and mitigation strategies. | PSNet
     psnet.ahrq.gov/issue/opioid-abuse-chronic-pain-misconceptions-and-mitigation-strategies
     November 18, 2016 - that contribute to this epidemic and clarifies current evidence to address misunderstandings about therapeutic … The authors suggest enhanced use of monitoring mechanisms and alternative therapies to promote safer

173. Specialist physicians' attitudes and practice patterns regarding disclosure of pre-referral medical errors. | PSNet
     psnet.ahrq.gov/issue/specialist-physicians-attitudes-and-practice-patterns-regarding-disclosure-pre-referral
     November 02, 2018 - Prior studies demonstrate that disclosure of medical errors to patients is central to maintaining a therapeutic

174. JAMA professionalism: disclosure of medical error. | PSNet
     psnet.ahrq.gov/issue/jama-professionalism-disclosure-medical-error
     December 19, 2018 - Disclosing medical errors to patients is essential for maintaining a therapeutic relationship and preventing

175. Fixed-dose combination antihypertensives and risk of medication errors. | PSNet
     psnet.ahrq.gov/issue/fixed-dose-combination-antihypertensives-and-risk-medication-errors
     September 28, 2016 - prescribing of antihypertensive fixed-dose combination medication was associated with a greater risk of therapeutic

176. Individualized medication review in older people with multimorbidity: a comparative analysis between patients living at home and in a nursing home. | PSNet
     psnet.ahrq.gov/issue/individualized-medication-review-older-people-multimorbidity-comparative-analysis-between
     May 04, 2022 - resulted in a greater decrease in risk factors for medication-related adverse events (e.g., polypharmacy, therapeutic … June 29, 2022 Patients who die by suicide: a study of treatment patterns and patient

177. Using Failure Mode, Effect and Criticality Analysis to improve safety in the cancer treatment prescription and administration process. | PSNet
     psnet.ahrq.gov/issue/using-failure-mode-effect-and-criticality-analysis-improve-safety-cancer-treatment
     October 21, 2020 - Using Failure Mode, Effect and Criticality Analysis to improve safety in the cancer treatment … Using Failure Mode, Effect and Criticality Analysis to improve safety in the cancer treatment prescription … Each phase of the cancer treatment process had at least one critical step identified, and actions were … Using Failure Mode, Effect and Criticality Analysis to improve safety in the cancer treatment prescription … June 9, 2021 Use of therapeutic outcomes monitoring method for performing of pharmaceutical

178. From the randomized AMBORA trial to clinical practice: comparison of medication errors in oral antitumor therapy. | PSNet
     psnet.ahrq.gov/issue/randomized-ambora-trial-clinical-practice-comparison-medication-errors-oral-antitumor-therapy
     April 21, 2021 - the randomized AMBORA trial to clinical practice: comparison of medication errors in oral antitumor therapy … April 21, 2021 Medication errors during treatment with new oral anticancer agents: consequences … 2024 Association of polypharmacy and potential drug-drug interactions with adverse treatment … July 19, 2023 Use of therapeutic outcomes monitoring method for performing of pharmaceutical … December 29, 2014 Minimising treatment-associated risks in systemic cancer therapy.

179. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49586/psn-pdf
     May 01, 2009 - dose was administered from the correct vial, and the patient's ACT time rapidly became appropriately therapeutic … infusions prepared in the OR or in procedure areas may not be the same concentration used in inpatient treatment … Progress has been and continues to be made to improve the safety of heparin therapy in inpatient settings … addition, the transition of patients from the OR to inpatient units may include continuation of heparin therapy … not require anesthesiologists to prepare IV flushes from vials of concentrated heparin intended for therapeutic

180. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49616/psn-pdf
     December 01, 2010 - Fortunately, dexamethasone has a wide therapeutic index associated with a single dose, and the patient … In such an approach, certain medications—high-alert, narrow therapeutic index, and highly toxic drugs—are … Medications with wide therapeutic indices and low toxicity profiles are particularly good candidates